These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


345 related items for PubMed ID: 32642919

  • 1. Efficacy of corticosteroid therapy for IgA nephropathy patients stratified by kidney function and proteinuria.
    Nagasawa Y, Yamamoto R, Shinzawa M, Shoji T, Hasuike Y, Nagatoya K, Yamauchi A, Hayashi T, Kuragano T, Moriyama T, Isaka Y.
    Clin Exp Nephrol; 2020 Oct; 24(10):927-934. PubMed ID: 32642919
    [Abstract] [Full Text] [Related]

  • 2. Corticosteroid therapy in IgA nephropathy with minimal proteinuria and high renal pathological score: A single‑center cohort study.
    Tang Y, He H, Sun W, Hu P, Chen X, Xu X.
    Mol Med Rep; 2018 Oct; 18(4):4103-4112. PubMed ID: 30132546
    [Abstract] [Full Text] [Related]

  • 3. Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children.
    Kang Z, Li Z, Duan C, Wu T, Xun M, Ding Y, Zhang Y, Zhang L, Yin Y.
    Pediatr Nephrol; 2015 Jul; 30(7):1121-9. PubMed ID: 25773534
    [Abstract] [Full Text] [Related]

  • 4. Significance of clinical and morphological prognostic risk factors in IgA nephropathy: follow-up study of comparison patient groups with and without renoprotection.
    Riispere Ž, Kuudeberg A, Seppet E, Sepp K, Ilmoja M, Luman M, Kõlvald K, Auerbach A, Ots-Rosenberg M.
    BMC Nephrol; 2017 Mar 14; 18(1):89. PubMed ID: 28292274
    [Abstract] [Full Text] [Related]

  • 5. Are children with IgA nephropathy different from adult patients?
    Su B, Jiang Y, Li Z, Zhou J, Rong L, Feng S, Zhong F, Sun S, Zhang D, Xia Z, Feng C, Huang W, Li X, Chen C, Hao Z, Wang M, Qin L, Chen M, Li Y, Ding J, Bao Y, Liu X, Deng F, Cheng X, Zhang L, Zhang X, Yang H, Peng X, Sun Q, Deng L, Jiang X, Xie M, Gao Y, Yu L, Liu L, Gao C, Mao J, Zheng W, Dang X, Xia H, Wang Y, Zhong X, Ding J, Lv J, Zhang H.
    Pediatr Nephrol; 2024 Aug 14; 39(8):2403-2412. PubMed ID: 38578470
    [Abstract] [Full Text] [Related]

  • 6. Long-term safety and efficacy of hydroxychloroquine in patients with IgA nephropathy: a single-center experience.
    Tang C, Lv JC, Shi SF, Chen YQ, Liu LJ, Zhang H.
    J Nephrol; 2022 Mar 14; 35(2):429-440. PubMed ID: 33591553
    [Abstract] [Full Text] [Related]

  • 7. Corticosteroid in IgA nephropathy with moderate proteinuria: A retrospective cohort study.
    Wang Y, Yu J, Jiang Y, Li J, Yimamuyushan A, Xia X, Fan L, Huang F, Chen W, Liu Q.
    Nephrology (Carlton); 2024 May 14; 29(5):268-277. PubMed ID: 38186010
    [Abstract] [Full Text] [Related]

  • 8. Effects of Two Immunosuppressive Treatment Protocols for IgA Nephropathy.
    Rauen T, Fitzner C, Eitner F, Sommerer C, Zeier M, Otte B, Panzer U, Peters H, Benck U, Mertens PR, Kuhlmann U, Witzke O, Gross O, Vielhauer V, Mann JFE, Hilgers RD, Floege J.
    J Am Soc Nephrol; 2018 Jan 14; 29(1):317-325. PubMed ID: 29042456
    [Abstract] [Full Text] [Related]

  • 9. Impact of the number of steroid pulses in tonsillectomy combined with steroid pulse therapy: a nationwide retrospective study in Japan.
    Moriyama T, Kataoka H, Nitta K, Hirano K, Matsuzaki K, Yasuda T, Yasuda Y, Koike K, Maruyama S, Yokoo T, Matsuo S, Kawamura T, Suzuki Y.
    Clin Exp Nephrol; 2021 Jan 14; 25(1):19-27. PubMed ID: 32880761
    [Abstract] [Full Text] [Related]

  • 10. Changes in Proteinuria and Side Effects of Corticosteroids Alone or in Combination with Azathioprine at Different Stages of IgA Nephropathy.
    Sarcina C, Tinelli C, Ferrario F, Pani A, De Silvestri A, Scaini P, Del Vecchio L, Alberghini E, Buzzi L, Baragetti I, Pozzi C.
    Clin J Am Soc Nephrol; 2016 Jun 06; 11(6):973-981. PubMed ID: 27129712
    [Abstract] [Full Text] [Related]

  • 11. Corticosteroids in IgA Nephropathy: A Retrospective Analysis from the VALIGA Study.
    Tesar V, Troyanov S, Bellur S, Verhave JC, Cook HT, Feehally J, Roberts IS, Cattran D, Coppo R, VALIGA study of the ERA-EDTA Immunonephrology Working Group.
    J Am Soc Nephrol; 2015 Sep 06; 26(9):2248-58. PubMed ID: 25677392
    [Abstract] [Full Text] [Related]

  • 12. The predictive value of attenuated proteinuria at 1 year after steroid therapy for renal survival in patients with IgA nephropathy.
    Hirano K, Kawamura T, Tsuboi N, Okonogi H, Miyazaki Y, Ikeda M, Matsushima M, Hanaoka K, Ogura M, Utsunomiya Y, Hosoya T.
    Clin Exp Nephrol; 2013 Aug 06; 17(4):555-62. PubMed ID: 23224025
    [Abstract] [Full Text] [Related]

  • 13. Treatment of IgA nephropathy.
    Pozzi C.
    J Nephrol; 2016 Feb 06; 29(1):21-5. PubMed ID: 26577268
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of corticosteroids in immunoglobulin A nephropathy with less than 25% crescents.
    Chen J, Xu H, Peng Z, Lin L, Li C, Zhu X, Liu S.
    Clin Exp Nephrol; 2020 Jan 06; 24(1):73-81. PubMed ID: 31605314
    [Abstract] [Full Text] [Related]

  • 15. Corticosteroids could improve the renal outcome of IgA nephropathy with moderate proteinuria.
    Zhong Z, Tang Y, Tan J, Tan L, Pei G, Qin W.
    Int Urol Nephrol; 2021 Jan 06; 53(1):121-127. PubMed ID: 32944888
    [Abstract] [Full Text] [Related]

  • 16. Combination therapy of low-dose cyclosporine and steroid in adults with IgA nephropathy
.
    Ihm HS, Lee JY, Hwang HS, Kim YG, Moon JY, Lee SH, Jeong KH, Lee TW, Ihm CG.
    Clin Nephrol; 2019 Sep 06; 92(3):131-140. PubMed ID: 31232271
    [Abstract] [Full Text] [Related]

  • 17. Albumin-to-fibrinogen ratio is an independent predictor of corticosteroid response and prognosis in patients with IgA nephropathy.
    Zhang Y, Man L.
    Eur J Med Res; 2023 Apr 03; 28(1):146. PubMed ID: 37013663
    [Abstract] [Full Text] [Related]

  • 18. Use of corticosteroids in Norwegian patients with immunoglobulin a nephropathy progressing to end-stage kidney disease: a retrospective cohort study.
    Rivedal M, Haaskjold YL, Eikrem Ø, Bjørneklett R, Marti HP, Knoop T.
    BMC Nephrol; 2024 Jan 29; 25(1):42. PubMed ID: 38287343
    [Abstract] [Full Text] [Related]

  • 19. Immunosuppressant Agents as Add-On Therapy Failed to Improve the Outcome of Immunoglobulin A Nephropathy with Crescent Score C1.
    Bi X, Yu Y, Zhou S, Zhou Y, Zhao J, Xiong J.
    Nephron; 2024 Jan 29; 148(9):587-600. PubMed ID: 38723614
    [Abstract] [Full Text] [Related]

  • 20. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
    Moriyama T, Honda K, Nitta K, Yumura W, Nihei H.
    Clin Exp Nephrol; 2004 Sep 29; 8(3):237-42. PubMed ID: 15480901
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.